Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FOGT5: TS-stratified chemotherapy in advanced colorectal cancer
NCT01212718Phase 2Completed
- Sponsor
- Ulm University
- Start
- Jul 2001
- Primary completion
- Jun 2010
- Modality
- Nanoparticles, Monoclonal Antibodies, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of irinotecan hydrochloride liposome injection (II) + temozolomide + bevacizumab in colorectal cancer (CRC), sponsored by Ulm University. Started Jul 2001; status: completed.
02
Drugs
irinotecan hydrochloride liposome injection (II) + temozolomide + bevacizumab
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT01212718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01212718.